Episodic rage associated with primary aldosteronism resolved with adrenalectomy

Psychotherapy and Psychosomatics

Volumn 80, Issue 5, 2011, Pages 306-307

  Houlihan, David J ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; AMLODIPINE; CLONIDINE; HYDROCHLOROTHIAZIDE; LISINOPRIL; LORAZEPAM; METADRENALIN; METOPROLOL; POTASSIUM; RISPERIDONE; SERTRALINE; SPIRONOLACTONE; TRAZODONE; VALPROATE SEMISODIUM;

ADRENALECTOMY; ADULT; ALDOSTERONE BLOOD LEVEL; ANAMNESIS; ANTIHYPERTENSIVE THERAPY; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; HUMAN; HYPERTENSION; HYPOKALEMIA; IMPULSE CONTROL DISORDER; LAPAROSCOPIC SURGERY; LETTER; MAJOR DEPRESSION; MALE; MOOD DISORDER; PATHOPHYSIOLOGY; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; RAGE; TREATMENT RESPONSE;

ADRENALECTOMY; HUMANS; HYPERALDOSTERONISM; MALE; MIDDLE AGED; RAGE;

EID: 79959647580     PISSN: 00333190     EISSN: 14230348     Source Type: Journal    
DOI: 10.1159/000323618     Document Type: Letter

References (18)

1. Sonino N, Fallo F, Fava GA: Psychological aspects of primary aldosteronism. Psychother Psychosom 2006; 75: 327-330. (Pubitemid 44200481)
2. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young WF Jr, Montori VM, Endocrine Society: Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2008; 93: 3266-3281.
3. Fava GA, Freyberger HJ, Bech P, Christodoulou G, Sensky T, Theorell T, Wise TN: Diagnostic criteria for use in psychosomatic research. Psychother Psychosom 1995; 63: 1-8.
4. Lim PO, Rodgers P, Cardale K, Watson AD, MacDonald TM: Potentially high prevalence of primary aldosteronism in a primary-care population. Lancet 1999; 353: 40. (Pubitemid 29037708)
5. Khurshid KA, Weaver ME: Hyperaldosteronism (Conn's disease) presenting as depression. J Clin Psychiatry 1979; 40: 358-359.
6. Avery L: Primary hyperaldosteronism and depression. NZ Med J 1984; 97: 537.
7. Goldberg RJ, Posner DA: Anxiety in medically ill; in Stoudemire A, Fogel BS, Greenberg BD (eds): Psychiatric Care of the Medical Patient. New York, Oxford University Press, 2000, pp 165-180.
8. Sukor N, Kogovsek C, Gordon RD, Robson D, Stowasser M: Improved quality of life, blood pressure, and biochemical status following laparoscopic adrenalectomy for unilateral primary aldosteronism. J Clin Endocrinol Metab 2010; 95: 1360-1364.
9. Kubzansky LD, Adler GK: Aldosterone: a forgotten mediator of the relationship between psychological stress and heart disease. Neurosci Biobehav Rev 2010; 34: 80-86.
10. de Kloet ER, Vreugdenhil E, Oitzl MS, Joëls M: Brain corticosteroid receptor balance in health and disease. Endocr Rev 1998; 19: 269-301. (Pubitemid 29117816)
11. Korte SM, de Boer SF, de Kloet ER, Bohus B: Anxiolytic-like effects of selective mineralocorticoid and glucocorticoid antagonists on fear-enhanced behavior in the elevated plus-maze. Psychoneuroendocrinology 1995; 20: 385-394.
12. Smythe JW, Murphy D, Timothy C, Costall B: Hippocampal mineralocorticoid, but not glucocorticoid, receptors modulate anxiety-like behavior in rats. Pharmacol Biochem Behav 1997; 56: 507-513. (Pubitemid 27145833)
13. de Kloet ER, Joëls M, Holsboer F: Stress and the brain: from adaptation to disease. Nat Rev Neurosci 2005; 6: 463-475. (Pubitemid 40769171)
14. de Kloet ER, van Acker S, Sibug RM, Oitzl MS, Meijer OC, Rahmouni K, de Jong W: Brain mineralocorticoid receptors and centrally regulated functions. Kidney Int 2000; 57: 1329-1336. (Pubitemid 30207887)
15. Rozeboom AM, Akil H, Seasholtz AF: Mineralocorticoid receptor overexpression in forebrain decreases anxiety-like behavior and alters the stress response in mice. Proc Natl Acad Sci USA 2007; 104: 4688-4693. (Pubitemid 47186286)
16. Hlavacova N, Jezova D: Chronic treatment with the mineralocorticoid hormone aldosterone results in increased anxiety-like behavior. Horm Behav 2008; 54: 90-97.
17. Armanini D, Witzgall H, Strasser T, Weber PC: Mineralocorticoid and glucocorticoid receptors in circulating mononuclear leukocytes of patients with primary hyperaldosteronism. Cardiology 1985; 72: 99-101. (Pubitemid 16146023)
18. Armanini D, Witzgall H, Wehling M, Kuhnle U, Weber PC: Aldosterone receptors in different types of primary hyperaldosteronism. J Clin Endocrinol Metab 1987; 65: 101-104. (Pubitemid 17092095)